{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:39:17Z","timestamp":1792532357765,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Innovative Drug Research and Develoment National Science and Technology Major Project","award":["2025ZD1804204"],"award-info":[{"award-number":["2025ZD1804204"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Respiratory syncytial virus (RSV) remains a major cause of severe lower respiratory tract disease in infants, older adults, and immunocompromised individuals, underscoring the need for vaccine strategies that balance systemic protection with frontline respiratory immunity. Although adenoviral and RNA-based RSV are both promising platforms, how the platform itself shapes systemic versus respiratory mucosal immunity under the same antigenic context remains insufficiently defined. We conducted a head-to-head comparison of an LNP-delivered saRNA vaccine (LNP-RSV-preF saRNA) and a recombinant Ad5-vectored vaccine (Ad5-RSV-preF) in mice using intramuscular prime-boost immunization. The two platforms drove distinct immune architectures rather than just differences in response magnitude. LNP-RSV-preF saRNA preferentially promoted respiratory mucosal immunity, including elevated BALF IgG, pulmonary antibody-secreting cells, CD69\n                    <jats:sup>+<\/jats:sup>\n                    T cells, and lung-resident memory T (TRM) cells, as well as cycling and memory-associated CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell states and durable lung IgA memory. In contrast, Ad5-RSV-preF induced stronger systemic immunity, featured by higher early serum IgG, splenic polyfunctional effector T cells, enhanced germinal center\/TFH responses, and effector-polarized CD8\u2009+\u2009T cells, with sustained systemic humoral memory. Ad5-vectored and LNP-saRNA vaccine platforms induce distinct compartmentalized immune responses to the same RSV preF antigen. This study establishes a framework for rational platform selection in RSV vaccine design, enabling tailored strategies to balance systemic immunity and respiratory mucosal memory.\n                  <\/jats:p>","DOI":"10.1038\/s44321-026-00537-y","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:37:57Z","timestamp":1792485477000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intramuscular self-amplifying RNA and adenoviral RSV vaccines program distinct systemic and respiratory mucosal immune architectures"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2023-4627","authenticated-orcid":false,"given":"Yao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3687-0853","authenticated-orcid":false,"given":"Yu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongbing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingzhe","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuejun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boduan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5440-5941","authenticated-orcid":false,"given":"Ping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"537_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1128\/CVI.00609-15","volume":"23","author":"PL Acosta","year":"2015","unstructured":"Acosta PL, Caballero MT, Polack FP (2015) Brief history and characterization of enhanced respiratory syncytial virus disease. Clin Vaccin Immunol 23:189\u2013195","journal-title":"Clin Vaccin Immunol"},{"key":"537_CR2","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","volume":"40","author":"AJ Barbier","year":"2022","unstructured":"Barbier AJ, Jiang AY, Zhang P, Wooster R, Anderson DG (2022) The clinical progress of mRNA vaccines and immunotherapies. Nat Biotechnol 40:840\u2013854","journal-title":"Nat Biotechnol"},{"key":"537_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00912-1","volume":"9","author":"C Bissett","year":"2024","unstructured":"Bissett C, Belij-Rammerstorfer S, Ulaszewska M, Smith H, Kailath R, Morris S, Powers C, Sebastian S, Sharpe HR, Allen ER et al (2024) Systemic prime mucosal boost significantly increases protective efficacy of bivalent RSV influenza viral vectored vaccine. NPJ Vaccines 9:118","journal-title":"NPJ Vaccines"},{"key":"537_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-025-01205-x","volume":"10","author":"P Chai","year":"2025","unstructured":"Chai P, Shi Y, Li X, Yang M, Liu X, Liu M, Yu J, Yin X, Li D, Li K et al (2025) Improved mRNA-based RSV vaccine with PreF forming enveloped virus-like particles. NPJ Vaccines 10:152","journal-title":"NPJ Vaccines"},{"key":"537_CR5","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1126\/science.aav9033","volume":"365","author":"MC Crank","year":"2019","unstructured":"Crank MC, Ruckwardt TJ, Chen M, Morabito KM, Phung E, Costner PJ, Holman LA, Hickman SP, Berkowitz NM, Gordon IJ et al (2019) A proof of concept for structure-based vaccine design targeting RSV in humans. Science 365:505\u2013509","journal-title":"Science"},{"key":"537_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33649-3","volume":"13","author":"R de Jong","year":"2022","unstructured":"de Jong R, Stockhofe-Zurwieden N, Bonsing J, Wang KF, Vandepaer S, Bouzya B, Toussaint JF, Dieussaert I, Song H, Steff AM (2022) ChAd155-RSV vaccine is immunogenic and efficacious against bovine RSV infection-induced disease in young calves. Nat Commun 13:6142","journal-title":"Nat Commun"},{"key":"537_CR7","doi-asserted-by":"publisher","first-page":"e1345","DOI":"10.1002\/cti2.1345","volume":"10","author":"A Elkashif","year":"2021","unstructured":"Elkashif A, Alhashimi M, Sayedahmed EE, Sambhara S, Mittal SK (2021) Adenoviral vector-based platforms for developing effective vaccines to combat respiratory viral infections. Clin Transl Immunol 10:e1345","journal-title":"Clin Transl Immunol"},{"key":"537_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0163-z","volume":"5","author":"AS Espeseth","year":"2020","unstructured":"Espeseth AS, Cejas PJ, Citron MP, Wang D, DiStefano DJ, Callahan C, Donnell GO, Galli JD, Swoyer R, Touch S et al (2020) Modified mRNA\/lipid nanoparticle-based vaccines expressing respiratory syncytial virus F protein variants are immunogenic and protective in rodent models of RSV infection. NPJ Vaccines 5:16","journal-title":"NPJ Vaccines"},{"key":"537_CR9","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1164\/rccm.201412-2256OC","volume":"191","author":"MS Habibi","year":"2015","unstructured":"Habibi MS, Jozwik A, Makris S, Dunning J, Paras A, DeVincenzo JP, de Haan CA, Wrammert J, Openshaw PJ, Chiu C (2015) Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with respiratory syncytial virus. Am J Respiratory Crit Care Med 191:1040\u20131049","journal-title":"Am J Respiratory Crit Care Med"},{"key":"537_CR10","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1093\/cid\/ciz659","volume":"70","author":"K Korsten","year":"2020","unstructured":"Korsten K, Bont LJ (2020) Sustained cellular and humoral immune responses from an adenoviral vector-based respiratory syncytial virus vaccine. Clin Infect Dis 70:2082\u20132083","journal-title":"Clin Infect Dis"},{"key":"537_CR11","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add3075","volume":"7","author":"M K\u00fcnzli","year":"2022","unstructured":"K\u00fcnzli M, O\u2019Flanagan SD, LaRue M, Talukder P, Dileepan T, Stolley JM, Soerens AG, Quarnstrom CF, Wijeyesinghe S, Ye Y et al (2022) Route of self-amplifying mRNA vaccination modulates the establishment of pulmonary resident memory CD8 and CD4 T cells. Sci Immunol 7:eadd3075","journal-title":"Sci Immunol"},{"key":"537_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/s41392-024-02025-6","volume":"9","author":"H Lei","year":"2024","unstructured":"Lei H, Hong W, Yang J, He C, Zhou Y, Zhang Y, Alu A, Shi J, Liu J, Qin F et al (2024) Intranasal delivery of a subunit protein vaccine provides protective immunity against JN.1 and XBB-lineage variants. Signal Transduct Target Ther 9:311","journal-title":"Signal Transduct Target Ther"},{"key":"537_CR13","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/S0140-6736(22)00478-0","volume":"399","author":"Y Li","year":"2022","unstructured":"Li Y, Wang X, Blau DM, Caballero MT et al (2022) Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet 399:2047\u20132064","journal-title":"Lancet"},{"key":"537_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.920256","volume":"13","author":"C Maier","year":"2022","unstructured":"Maier C, Fuchs J, Irrgang P, Wi\u00dfing MH, Beyerlein J, Tenbusch M, Lapuente D (2022) Mucosal immunization with an adenoviral vector vaccine confers superior protection against RSV compared to natural immunity. Front Immunol 13:920256","journal-title":"Front Immunol"},{"key":"537_CR15","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.mucimm.2023.05.012","volume":"16","author":"AMW Malloy","year":"2023","unstructured":"Malloy AMW, Lu Z, Kehl M, Pena DaMata J, Lau-Kilby AW, Turfkruyer M (2023) Increased innate immune activation induces protective RSV-specific lung-resident memory T cells in neonatal mice. Mucosal Immunol 16:593\u2013605","journal-title":"Mucosal Immunol"},{"key":"537_CR16","doi-asserted-by":"publisher","first-page":"e295","DOI":"10.1016\/S1473-3099(18)30292-5","volume":"18","author":"NI Mazur","year":"2018","unstructured":"Mazur NI, Higgins D, Nunes MC, Melero JA, Langedijk AC, Horsley N, Buchholz UJ, Openshaw PJ, McLellan JS, Englund JA et al (2018) The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates. Lancet Infect Dis 18:e295\u2013e311","journal-title":"Lancet Infect Dis"},{"key":"537_CR17","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.immuni.2016.09.001","volume":"45","author":"L Mesin","year":"2016","unstructured":"Mesin L, Ersching J, Victora GD (2016) Germinal center B cell dynamics. Immunity 45:471\u2013482","journal-title":"Immunity"},{"key":"537_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.15585\/mmwr.mm7432a3","volume":"74","author":"DL Moulia","year":"2025","unstructured":"Moulia DL, Link-Gelles R, Chu HY et al (2025) Use of clesrovimab for prevention of severe respiratory syncytial virus-associated lower respiratory tract infections in infants: recommendations of the advisory committee on immunization practices\u2014United States. MMWR Morb Mortal Wkly Rep 2025 74:508\u2013514","journal-title":"MMWR Morb Mortal Wkly Rep 2025"},{"key":"537_CR19","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/d41573-024-00095-3","volume":"23","author":"A Mullard","year":"2024","unstructured":"Mullard A (2024) FDA approves mRNA-based RSV vaccine. Nat Rev Drug Discov 23:487","journal-title":"Nat Rev Drug Discov"},{"key":"537_CR20","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.3389\/fimmu.2018.02220","volume":"9","author":"K Nakagome","year":"2018","unstructured":"Nakagome K, Nagata M (2018) Involvement and possible role of eosinophils in asthma exacerbation. Front Immunol 9:2220","journal-title":"Front Immunol"},{"key":"537_CR21","doi-asserted-by":"publisher","first-page":"00269","DOI":"10.1183\/23120541.00269-2025","volume":"11","author":"D Padawer","year":"2025","unstructured":"Padawer D, Friedman A, Stolovich-Rain M, Darawshy F, Billan M, Kuint R, Cohen Goichman P, Abu Rmeileh A, Fridlender ZG, Wolf D et al (2025) BNT162b2 vaccine induces potent SARS-CoV-2 neutralising immunoglobulins in lung mucosa. ERJ Open Res 11:00269\u201302025","journal-title":"ERJ Open Res"},{"key":"537_CR22","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi N, Hogan MJ, Porter FW, Weissman D (2018) mRNA vaccines\u2014a new era in vaccinology. Nat Rev Drug Discov 17:261\u2013279","journal-title":"Nat Rev Drug Discov"},{"key":"537_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00734-7","volume":"8","author":"TJ Ruckwardt","year":"2023","unstructured":"Ruckwardt TJ (2023) The road to approved vaccines for respiratory syncytial virus. NPJ Vaccines 8:138","journal-title":"NPJ Vaccines"},{"key":"537_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/CMR.00090-16","volume":"30","author":"CD Russell","year":"2017","unstructured":"Russell CD, Unger SA, Walton M, Schwarze J (2017) The human immune response to respiratory syncytial virus infection. Clin Microbiol Rev 30:481\u2013502","journal-title":"Clin Microbiol Rev"},{"key":"537_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.957107","volume":"13","author":"MW Russell","year":"2022","unstructured":"Russell MW, Mestecky J (2022) Mucosal immunity: the missing link in comprehending SARS-CoV-2 infection and transmission. Front Immunol 13: 957107","journal-title":"Front Immunol"},{"key":"537_CR26","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/infdis\/jiab003","volume":"226","author":"J Sadoff","year":"2021","unstructured":"Sadoff J, De Paepe E, DeVincenzo J, Gymnopoulou E, Menten J, Murray B, Rosemary Bastian A, Vandebosch A, Haazen W, Noulin N et al (2021) Prevention of respiratory syncytial virus infection in healthy adults by a single immunization of Ad26.RSV.preF in a human challenge study. J Infect Dis 226:396\u2013406","journal-title":"J Infect Dis"},{"key":"537_CR27","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/nprot.2013.058","volume":"8","author":"G Saletti","year":"2013","unstructured":"Saletti G, \u00c7uburu N, Yang JS, Dey A, Czerkinsky C (2013) Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood. Nat Protoc 8:1073\u20131087","journal-title":"Nat Protoc"},{"key":"537_CR28","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.coviro.2013.05.003","volume":"3","author":"CA Shaw","year":"2013","unstructured":"Shaw CA, Ciarlet M, Cooper BW, Dionigi L, Keith P, O\u2019Brien KB, Rafie-Kolpin M, Dormitzer PR (2013) The path to an RSV vaccine. Curr Opin Virol 3:332\u2013342","journal-title":"Curr Opin Virol"},{"key":"537_CR29","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","volume":"390","author":"T Shi","year":"2017","unstructured":"Shi T, McAllister DA, O\u2019Brien KL et al (2017) Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet 390:946\u2013958","journal-title":"Lancet"},{"key":"537_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2024.105823","volume":"223","author":"D Sinha","year":"2024","unstructured":"Sinha D, Yaugel-Novoa M, Waeckel L, Paul S, Longet S (2024) Unmasking the potential of secretory IgA and its pivotal role in protection from respiratory viruses. Antivir Res 223:105823","journal-title":"Antivir Res"},{"key":"537_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30913-4","volume":"13","author":"A Ssemaganda","year":"2022","unstructured":"Ssemaganda A, Nguyen HM, Nuhu F, Jahan N, Card CM, Kiazyk S, Severini G, Keynan Y, Su RC, Ji H et al (2022) Expansion of cytotoxic tissue-resident CD8(+) T cells and CCR6(+)CD161(+) CD4(+) T cells in the nasal mucosa following mRNA COVID-19 vaccination. Nat Commun 13:3357","journal-title":"Nat Commun"},{"key":"537_CR32","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1128\/JVI.01536-14","volume":"89","author":"YC Su","year":"2015","unstructured":"Su YC, Townsend D, Herrero LJ, Zaid A, Rolph MS, Gahan ME, Nelson MA, Rudd PA, Matthaei KI, Foster PS et al (2015) Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease. J Virol 89:1564\u20131578","journal-title":"J Virol"},{"key":"537_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0200-y","volume":"5","author":"L van der Fits","year":"2020","unstructured":"van der Fits L, Bolder R, Heemskerk-van der Meer M, Drijver J, van Polanen Y, Serroyen J, Langedijk JPM, Schuitemaker H, Saeland E, Zahn R (2020) Adenovector 26 encoded prefusion conformation stabilized RSV-F protein induces long-lasting Th1-biased immunity in neonatal mice. NPJ Vaccines 5:49","journal-title":"NPJ Vaccines"},{"key":"537_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/d41586-023-01529-5","volume":"617","author":"M Vidal Valero","year":"2023","unstructured":"Vidal Valero M (2023) \u2018A good day\u2019: FDA approves world\u2019s first RSV vaccine. Nature 617:234\u2013235","journal-title":"Nature"},{"key":"537_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54289-9","volume":"15","author":"A Vijayan","year":"2024","unstructured":"Vijayan A, Vogels R, Groppo R, Jin Y, Khan S, Van Kampen M, Jorritsma S, Boedhoe S, Baert M, van Diepen H et al (2024) A self-amplifying RNA RSV prefusion-F vaccine elicits potent immunity in pre-exposed and na\u00efve non-human primates. Nat Commun 15:9884","journal-title":"Nat Commun"},{"key":"537_CR36","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s44298-024-00073-x","volume":"2","author":"Z Wang","year":"2024","unstructured":"Wang Z, Zhong M, Thomas C, Kinnear E, Rice T, Holder B, Kampmann B, Tregoning JS (2024) Modulating cytokine microenvironment during T cell activation induces protective RSV-specific lung resident memory T cells in early life in mice. NPJ Viruses 2:71","journal-title":"NPJ Viruses"},{"key":"537_CR37","doi-asserted-by":"publisher","first-page":"5406","DOI":"10.1016\/j.vaccine.2015.08.056","volume":"33","author":"MN Widjojoatmodjo","year":"2015","unstructured":"Widjojoatmodjo MN, Bogaert L, Meek B, Zahn R, Vellinga J, Custers J, Serroyen J, Rado\u0161evi\u0107 K, Schuitemaker H (2015) Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats. Vaccine 33:5406\u20135414","journal-title":"Vaccine"},{"key":"537_CR38","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/infdis\/jiaa193","volume":"222","author":"K Williams","year":"2020","unstructured":"Williams K, Bastian AR, Feldman RA, Omoruyi E, de Paepe E, Hendriks J, van Zeeburg H, Godeaux O, Langedijk JPM, Schuitemaker H et al (2020) Phase 1 safety and immunogenicity study of a respiratory syncytial virus vaccine with an adenovirus 26 vector encoding prefusion F (Ad26.RSV.preF) in adults aged \u226560 years. J Infect Dis 222:979\u2013988","journal-title":"J Infect Dis"},{"key":"537_CR39","doi-asserted-by":"publisher","first-page":"817113","DOI":"10.3389\/fimmu.2022.817113","volume":"13","author":"D Zhang","year":"2022","unstructured":"Zhang D, Yang J, Zhao Y, Shan J, Wang L, Yang G, He S, Li E (2022) RSV infection in neonatal mice induces pulmonary eosinophilia responsible for asthmatic reaction. Front Immunol 13:817113","journal-title":"Front Immunol"},{"key":"537_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109401","volume":"36","author":"B Zhao","year":"2021","unstructured":"Zhao B, Yang J, He B, Li X, Yan H, Liu S, Yang Y, Zhou D, Liu B, Fan X et al (2021) A safe and effective mucosal RSV vaccine in mice consisting of RSV phosphoprotein and flagellin variant. Cell Rep 36:109401","journal-title":"Cell Rep"},{"key":"537_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.chom.2021.11.006","volume":"30","author":"T Zohar","year":"2022","unstructured":"Zohar T, Hsiao JC, Mehta N, Das J, Devadhasan A, Karpinski W, Callahan C, Citron MP, DiStefano DJ, Touch S et al (2022) Upper and lower respiratory tract correlates of protection against respiratory syncytial virus following vaccination of nonhuman primates. Cell Host Microbe 30:41\u201352.e45","journal-title":"Cell Host Microbe"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00537-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00537-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-026-00537-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:01:55Z","timestamp":1792530115000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-026-00537-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":41,"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1038\/s44321-026-00537-y","relation":{},"ISSN":["1757-4684"],"issn-type":[{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"8 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}]}}